About: A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Lorenzo Pilla et al published 8 October 2005 in Cancer Immunology, Immunotherapy

AttributesValues
rdf:type
description
  • artículu científicu (ast)
  • wetenschappelijk artikel (nl)
  • article scientifique publié en 2005 (fr)
  • наукова стаття, опублікована в жовтні 2005 (uk)
  • im Oktober 2005 veröffentlichter wissenschaftlicher Artikel (de)
  • 2005 ഒക്ടോബര്‍ 8 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം (ml)
  • article by Lorenzo Pilla et al published 8 October 2005 in Cancer Immunology, Immunotherapy (en)
publication date
publication date
exact match
exact match
cites work
cites work
author name string
author name string
  • Giorgio Parmiani
  • Axel Hoos
  • Daisuke Nonaka
  • Elisabetta Pennacchioli
  • Adriano Piris
  • Ilaria Bersani
  • Annabella Di Florio
  • Lorenzo Pilla
  • Flavio Arienti
  • Pramod K. Srivastava
  • Cristina Santantonio
  • Agata Cova
  • Diego Tosi
  • Elda Lamaj
  • Gloria Sovena
  • Mariani Luigi
rdfs:label
  • A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (en)
  • A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (nl)
skos:prefLabel
  • A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (en)
  • A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (nl)
name
  • A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (en)
  • A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (nl)
author
author
title
title
  • A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (en)
page(s)
page(s)
  • 958-968
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 16215718
published in
published in
issue
volume
issue
  • 8
volume
  • 55
DOI
DOI
DOI
  • 10.1007/S00262-005-0084-8
is about of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software